Table 2.
Pharmacological therapies and associated diseases of the compared samples.
| Patients with tinnitus (n=130) | Control group (n=100) | P-value | |
|---|---|---|---|
| Gender (male)(Freq.(%)) | 75 (57.69) | 54 | n.s |
| Drugs | 73 (56.15) | 51 | n.s |
| Antihypertensive | 32 (24.62) | 23 | n.s |
| Diuretics | 14 (10.77) | 10 | n.s |
| Cortisone | 5 (3.85) | 3 | n.s |
| Levothyroxine | 27 (20.77) | 10 | 0.08 |
| Hypoglycemic drugs | 12 (9.23) | 7 | n.s |
| Proton-pump inhibitors | 20 (15.38) | 7 | 0.02 |
| Antidepressants | 14 (10.77) | 5 | n.s |
| Associated diseases | |||
| TMJ Disorders | 63 (48.46) | 33 | 0.001 |
| Headache | 59 (45.38) | 31 | 0.001 |
| Neurological disorders | 12 (9.23) | 2 | 0.02 |
| Depression | 35 (26.92) | 6 | 0.001 |
| Anxiety | 71 (54.62) | 36 | 0.001 |
| Cardiovascular diseases | 14 (10.77) | 17 | n.s |
| Hypertension | 38 (29.23) | 21 | n.s |
| Diabetes | 14 (10.77) | 7 | n.s |
| Dyslipidemia | 9 (6.92) | 7 | n.s |
| Dysthyroidism | 34 (26.15) | 12 | 0.001 |